Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Maravai Lifesciences Holdings Inc (MRVI)

NASDAQ
Currency in USD
Disclaimer
7.30
-0.31(-4.07%)
Closed
After Hours
7.300.00(0.00%)

MRVI Comments

What happens with this stock
Only down
$MRVI Maintains KeyBanc Overweight USD 39 » USD 46 Maintains Credit Suisse Outperform USD 34 » USD 42
It's a rocket! Revenue of $98.4 million for the fourth quarter and $284.1 million for the full year of 2020, representing 173.5% and 98.5% increases, respectively, over the corresponding periods of 2019; Net income (loss) and Adjusted EBITDA was $78.8 million and $169.2 million, respectively, for the year ended December 31, 2020, compared to $(5.2) million and $62.0 million, respectively, for the prior year. Established 2021 revenue guidance of $580.0 million to $630.0 million, representing growth of 104.2% to 121.8%. https://finance.yahoo.com/news/maravai-lifesciences-reports-fourth-quarter-210500901.html
Why does no one talk about this company? The company has more than 5 thousand clients, including 20 leading world biopharmaceutical companies (including those testing anti-Covid drugs). For 9M2020, revenues was at $186m vs $143m for the whole 2019 ($124m for 2018); Net profit for 9m2020 was at $64m vs net loss of $5m for the whole 2019 (-$17m for 2018). I suppose it should demonstrate great results for YE2020 on March 2 - demand for its products from pharmaceutical companies should be high. => Bullish
Am I the only one who sees EUR/USD page instead of MRVI
No. Same here.
Why is this page always broken
Maravai holds a number of patents and offers innovative products and services including CleanCap®, CleanAmp®, GMPLink™, Antibody Affinity Extraction™ (AAE™), EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV™, Sterling™, Glen Pak™, Glen Gel-Pak™, Poly-Pak™, VECTASTAIN® and VECTASHIELD®.
mthfk...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.